Sts Duotek, Inc.
Epilepsy is a debilitating disorder affecting 1 adult in 200 in the United States. Although several drugs are valuable for epilepsy therapy, their poor aqueous solubility does not permit effective for ...SBIR Phase II 1995 Department of Health and Human Services
Our company will formulate a protease inhibitor, KNI-272, to improve bioavailability following oraladministration. This will be accomplished using patented technology to convert this nearly water-inss ...SBIR Phase I 1995 Department of Health and Human Services
N/ASBIR Phase I 1993 Department of Health and Human Services